New work for the new year…
News
From new advances in the treatment of postpartum depression to digital therapeutics for the treatment of ADHD in children, here are highlights from the week in Psychiatric Times.
An accurate diagnosis?
Revisiting the CME articles featured in Psychiatric Times in 2022.
What is the most hopeful holiday around the world—and why is it more important this year than ever?
The experts weighed in on a wide variety of psychiatric issues for the December 2022 issue of Psychiatric Times.
That's one way to handle family drama...
Even when facing the most difficult opponents, it's possible to win a positive outcome.
VR-based training may help improve social cognition and functioning in patients with schizophrenia.
From current treatments for cannabis use disorder to new possibilities for the treatment of dementia, here are highlights from the week in Psychiatric Times.
A psychiatrist reflects on his story...
'Tis the season...
“We hold on to the promise because it continues to sustain us… and me.”
While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.
How can we open our minds?
"Dementia is a mental health condition that can make or break families. Remember that behind the difficult behavior is your loved one."
Instead of figuring out ways to help people die, what if we devoted our energy to helping them live, even and especially if they are dying?
How can we, as clinicians, humanize our field and provide better care for our patients?
Cariprazine is now FDA-approved as an adjunctive therapy to antidepressants.
What's the latest in dementia?
There has long been a social, ethical consensus that a physician should intervene not to end a person’s life…
We have been too slow to address the future risks of climate change.
“The mere legalization of MAID creates a serious and discriminatory danger…”
The novel atypical antipsychotic is already FDA-approved for the treatment of schizophrenia in adults.
"To be sure, we are still in the nascent stages of developing treatments. However, our armamentarium is steadily growing."
Why might awe be so important now?
From new legislation that would expand the US approach to mental health to drug abuse trends and treatment approaches for 2023, here are highlights from the week in Psychiatric Times.
What is your 2023 New Year's Resolution? We want to hear about it!
This could be a very enlightening chat...
A fourth-year medical student reflects on the non-traditional traditions that came from growing up in a 2-physician, 2-religion household.
Advertisement
Advertisement